Anxiety Disorders News

  • ADAA Lurasidone Appears Safe in Kids With Bipolar Depression Lurasidone, approved for bipolar depression in children and adolescents on the basis of 6-week findings from a phase 3 trial, is also safe and effective for up to 28 weeks, new open-label data show.
  • ADAA 'Fear of Fear' May Influence OCD, PTSD Outcomes Anxiety sensitivity, commonly referred to as the 'fear of fear,' may affect treatment outcomes in patients with OCD; treatment preference may influence anxiety sensitivity outcomes in patients with PTSD.

Anxiety Disorders Perspective

  • A 15-Year-Old Girl With Palpitations: USMLE Question A 15-year-old with type 1 diabetes mellitus and hypothyroidism presents after an episode of shaking and palpitations. What is causing her symptoms?
  • ADAA 2018 Read clinically focused news coverage of key developments from ADAA 2018

Anxiety Disorders Journal Articles